文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后心率变异性用于神经预后判断:来自巴黎登记研究的启示

Heart rate variability for neuro-prognostication after CA: Insight from the Parisian registry.
PubMed 文献 · Resuscitation · 2024-06-24
一句话结论心脏骤停后昏迷患者中,部分心率变异性指标与不良神经预后、EEG严重程度及瞳孔对光反射消失相关,但敏感性有限。

该回顾性单中心研究纳入2007至2021年间199例心脏骤停后持续昏迷并接受EEG的患者,从EEG记录的心电导联5分钟信号计算时域、频域和非线性域HRV指标,评估其对3个月神经预后的预测价值并与瞳孔对光反射、EEG、SSEP N20和NSE比较。预后良好组VLF、LF、LF/HF比值、SD2和DFA α1均高于预后不良组,这些指标在EEG模式严重程度和瞳孔对光反射消失不同分组间也存在差异,对不良预后预测特异性高但敏感性低。

要点

  • 199例心脏骤停后昏迷患者中73%预后不良(3个月CPC 3-4-5),预后良好组VLF 0.21 vs 0.09 ms2/Hz(p<0.01)、LF 0.07 vs 0.04 ms2/Hz(p=0.003)、LF/HF比值2.01 vs 1.01(p=0.008)均更高。
  • 非线性域指标SD2预后良好组15.1 vs 预后不良组10.2(p=0.016),DFA α1预后良好组1.03 vs 预后不良组0.78(p=0.002)。
  • 这些时频域和非线性域HRV参数可预测不良神经预后,特异性高但敏感性低。
  • HRV指标在EEG模式严重程度和瞳孔对光反射消失的不同分组间存在差异。
  • HRV指标与瞳孔对光反射、EEG、SSEP N20和NSE等其他预后标志物进行了比较。

适用人群与场景

  • 心脏骤停后持续昏迷并接受EEG检查的成人患者,2007至2021年间纳入199例,64%为男性,中位年龄60 [48.9-71.7]岁,76%为院外心脏骤停,30%初始为可除颤心律。

诊断标准与关键阈值

  • 神经预后不良定义为3个月时最佳CPC 3-4-5。
  • HRV指标从EEG记录心电导联的5分钟信号计算,频域分析区分极低频(VLF 0.003-0.04 Hz)、低频(LF 0.04-0.15 Hz)、高频(HF 0.15-0.4 Hz)及LF/HF比值。

研究设计与关键结果

  • 回顾性单中心研究,纳入199例心脏骤停后持续昏迷并接受EEG的患者,评估HRV标志物对神经预后的预测价值及其与缺氧缺血性脑损伤严重程度的关联。
  • 3个月神经预后不良占73%;预后良好组VLF 0.21 vs 0.09 ms2/Hz(p<0.01)、LF 0.07 vs 0.04 ms2/Hz(p=0.003)、LF/HF比值2.01 vs 1.01(p=0.008)均高于预后不良组。
  • 非线性域指标预后良好组SD2 15.1 vs 10.2(p=0.016)、DFA α1 1.03 vs 0.78(p=0.002)均高于预后不良组。
  • 这些HRV指标在EEG模式严重程度和瞳孔对光反射消失的不同分组间存在差异。
  • 时频域和非线性域HRV参数预测不良神经预后特异性高但敏感性低。

证据类型、等级与局限

  • 证据类型:回顾性单中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,心脏骤停后昏迷患者中部分HRV标志物似乎与不良预后、EEG严重程度和瞳孔对光反射消失相关,但这些HRV标志物的敏感性仍然有限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hypoxic ischemic brain injury (HIBI) induced by cardiac arrest (CA) seems to predominate in cortical areas and to a lesser extent in the brainstem. These regions play key roles in modulating the activity of the autonomic nervous system (ANS), that can be assessed through analyses of heart rate variability (HRV). The objective was to evaluate the prognostic value of various HRV parameters to predict neurological outcome after CA.

METHODS: Retrospective monocentric study assessing the prognostic value of HRV markers and their association with HIBI severity. Patients admitted for CA who underwent EEG for persistent coma after CA were included. HRV markers were computed from 5 min signal of the ECG lead of the EEG recording. HRV indices were calculated in the time-, frequency-, and non-linear domains. Frequency-domain analyses differentiated very low frequency (VLF 0.003-0.04 Hz), low frequency (LF 0.04-0.15 Hz), high frequency (HF 0.15-0.4 Hz), and LF/HF ratio. HRV indices were compared to other prognostic markers: pupillary light reflex, EEG, N20 on somatosensory evoked potentials (SSEP) and biomarkers (neuron specific enolase-NSE). Neurological outcome at 3 months was defined as unfavorable in case of best CPC 3-4-5.

RESULTS: Between 2007 and 2021, 199 patients were included. Patients were predominantly male (64%), with a median age of 60 [48.9-71.7] years. 76% were out-of-hospital CA, and 30% had an initial shockable rhythm. Neurological outcome was unfavorable in 73%. Compared to poor outcome, patients with a good outcome had higher VLF (0.21 vs 0.09 ms2/Hz, p < 0.01), LF (0.07 vs 0.04 ms2/Hz, p = 0.003), and higher LF/HF ratio (2.01 vs 1.01, p = 0.008). Several non-linear domain indices were also higher in the good outcome group, such as SD2 (15.1 vs 10.2, p = 0.016) and DFA α1 (1.03 vs 0.78, p = 0.002). These indices also differed depending on the severity of EEG pattern and abolition of pupillary light reflex. These time-frequency and non-linear domains HRV parameters were predictive of poor neurological outcome, with high specificity despite a low sensitivity.

CONCLUSION: In comatose patients after CA, some HRV markers appear to be associated with unfavorable outcome, EEG severity and PLR abolition, although the sensitivity of these HRV markers remains limited.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Benghanem S, Sharshar T, Gavaret M, et al. Heart rate variability for neuro-prognostication after CA: Insight from the Parisian registry. Resuscitation. 2024. PMID: 38925291. doi:10.1016/j.resuscitation.2024.110294

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。